The present invention relates to a transgenic animal and methods for increasing the expression or activity of Sir2.alpha. protein. An increase in the expression of Sir2.alpha. protein prevents stress- and age-related cardiac cell death thereby facilitating the treatment of cardiac diseases or conditions associated with aging.